Biocracked
**Approach: Human outcome, with Palette C (natural).**

Close-up of a person's scalp and hairline, shot from slightly above and behind at a 3/4 angle, with a gloved dermatologist's hand parting dark brown hair to expose the follicles. The person is turned away, so the face is not shown. Soft morning window light comes in from the left and picks out individual hair shafts, fine vellus hairs and the texture of the skin. The background is a softly blurred sunlit room with green plant leaves and warm wood tones. A small amber dropper bottle, unlabeled, sits out of focus on a wooden shelf, with one tiny electric-green cap detail. The mood is calm, careful and investigative, like a real clinical check-up. Shallow depth of field, realistic skin tones, no text.
Peptides

The Hair-Growth Peptides That Scored Best in Human Trials (GHK-Cu Made the Cut)

Dr. Synapse · · 4 min read

The Hook: Hair-Growth Peptides Finally Got a Report Card

Search "peptides for hair loss" and you'll find serums with big promises and not much proof. A new systematic review in the Journal of Drugs in Dermatology (Joerg, Zafar and Jagdeo, 2026) is one of the more useful sorting efforts so far. It screened the human clinical literature and graded what held up. Three names came out on top, along with one lesser-known peptide: acetyl tetrapeptide-3, biotinoyl tripeptide-1, and GHK (the "copper peptide" family).

The grades are encouraging but modest, and the fine print matters.

How the Review Worked

The authors searched PubMed, Embase and the Cochrane Library on November 3, 2025, following PRISMA reporting guidelines. They looked for English-language clinical trials of peptide-containing therapies for hair loss in human subjects.

  • 981 studies were identified.
  • 14 trials met the inclusion criteria.
  • Each peptide or formulation received a grade of recommendation.

The abstract reports two tiers:

  • Grade B: formulations with acetyl tetrapeptide-3, biotinoyl tripeptide-1, glycyl-histidyl-lysine (GHK) peptide, and the penta-peptide Gly-Pro-Ile-Gly-Ser.
  • Grade C: QR678 and QR678 Neo®.

In most evidence-grading systems, B means reasonable but limited or inconsistent evidence, and C is weaker. Neither is the top tier. Grade B is not "proven," and it is not the kind of evidence behind long-established hair-loss drugs. The abstract doesn't spell out the grading scale, so check the full paper for the exact criteria.

The Peptides That Scored Best

Acetyl tetrapeptide-3 (often sold as Capixyl)

This is a short, lab-made peptide used in cosmetic hair serums. Commercial versions are often blended with plant-derived ingredients. It was one of the ingredients the authors singled out in their conclusion.

Biotinoyl tripeptide-1 (often sold as Procapil)

This is a peptide linked to biotin, the B vitamin people associate with hair. It is also a common ingredient in "hair density" serums, and the review gave it the same grade B.

GHK, the copper peptide (GHK-Cu)

GHK (glycyl-histidyl-lysine) is a small peptide best known in its copper-bound form. It has a long history in skincare and has more name recognition than the other two. It shares the grade B tier and is the third ingredient the authors highlighted.

The fourth Grade B entry

The penta-peptide Gly-Pro-Ile-Gly-Ser also earned a B. It gets far less attention in consumer products, and the abstract says little about it.

QR678 and QR678 Neo®

These got a C. QR678 is a branded formulation rather than a single peptide, and it generally appears in clinic-based treatment protocols rather than drugstore serums. The abstract doesn't describe how it was delivered in the included trials, so check the full text before drawing conclusions.

Topicals, Not Injections (Mostly)

The first three ingredients are mainly used in topical formulations such as serums, lotions and scalp products. That fits how they appear in the market, though the abstract itself says only "formulations." This is not the injectable-peptide scene you see in some wellness circles. The review covers peptide-containing hair products, not unregulated injectables, and it offers no evidence on those.

The Honest Limits

The paper's conclusion is positive, calling peptide formulations "effective, well-tolerated alternatives to conventional hair-growth therapies." Several caveats apply.

  • The pool is small. Fourteen trials across several different peptides means thin evidence for each one. The abstract doesn't report sample sizes, so I can't say how large the individual trials were. Given the grade B and C ratings, treat confidence as moderate at best.
  • Combinations muddy the picture. The authors highlight combinations containing these peptides. When a product has several actives, you can't tell which ingredient does the work, or whether the mix is what matters.
  • "Alternative" isn't "equal." The abstract doesn't report head-to-head results against approved drugs, and a grade B rating doesn't establish that peptides match them.
  • The abstract has no numbers. It gives no effect sizes, no hair-count changes and no timelines, so nobody can say how much regrowth to expect.
  • Safety is described only in general terms. "Well-tolerated" is the authors' summary, not a detailed safety analysis.
  • Everything here is human trial data, which is a strength. But the review is a literature synthesis, not a new trial, and its quality depends on the studies it pooled.

Practical Takeaways

Who might consider these? People with mild thinning who want a low-risk, non-prescription option and accept modest, uncertain results. Anyone with sudden, patchy or rapid hair loss should see a dermatologist first, because the cause matters and the review doesn't address diagnosis.

Using them with minoxidil? The abstract doesn't test peptides combined with minoxidil or any other drug, so there is no evidence-based recommendation either way. Peptide serums are commonly layered into routines alongside established treatments, but ask your dermatologist or pharmacist about sequencing and possible irritation.

  • Acetyl Tetrapeptide-3
  • Biotinoyl Tripeptide-1
  • Copper Tripeptide-1 (GHK-Cu)
  • Brand names like Capixyl or Procapil, which are marketing names for ingredient blends

Check the ingredient list for these names, not just front-label claims. Products often use them at unspecified concentrations, and the abstract gives no dose, so there's no verified "effective percentage." Follow the manufacturer's directions rather than guessing.

Timing: The abstract reports no trial durations. Hair grows slowly, so any real test of a product means consistent use over months, not weeks. Take photos under the same lighting to track change honestly.

Bottom Line

This review is a reasonable early map of the peptide hair-loss field. Three ingredients, plus a fourth lesser-known peptide, have enough human trial support to earn a B. That is a step above hype, but well short of settled science. If you try them, treat peptides as a low-risk experiment with modest expectations rather than a replacement for proven treatments, and let a clinician guide you if your hair loss is significant.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field.

A single frayed shoelace-style aglet stands in for a telomere cap: a glossy brass-tipped cord end, photographed in tight macro, its braided fibers splitting apart and unraveling at the worn end. The cord is cream white and the brass tip catches a crisp highlight. It rests on a seamless saturated mustard-yellow backdrop. The camera sits at a low three-quarter angle, with the frayed end sharp in the foreground and the rest of the cord falling softly out of focus to the right. Hard, directional studio light from the upper left casts a clean, short shadow on the yellow surface. A thin electric green thread runs through the braid, the only trace of green in the frame. Mood: skeptical, scrutinizing, a promise that doesn't hold together. No text anywhere.
peptides

Epitalon: The Telomere Peptide Everyone's Injecting Is Unproven

BY NOVA CHEN ·

Epitalon is pitched online as the telomere peptide that could slow aging, but a new 2026 review says the evidence tells a different story. Human data are limited to small biomarker studies and one older retinitis pigmentosa trial, with no adequately powered randomized trial showing efficacy. Dosing, pharmacokinetics, and long-term safety remain unvalidated, and questions about cancer risk, immunogenicity, product quality, and FDA scrutiny are still open. Here's what the science supports, what it doesn't, and who should steer clear.

Approach: the human outcome. Palette: C, natural.

A low-angle, side-on close shot of a sprinter's lower legs and spiked shoes at the start of a worn terracotta-red running track, just after sunrise. Low golden daylight rakes across the lane lines and picks out the sweat on the calf muscles and the tendons in the ankle. Behind the athlete, soft-focus green grass and a line of trees fill the background. The runner's face is out of frame. A single electric-green shoelace on one spiked shoe is the only accent. The depth of field is shallow, with the foreground track grain crisp and the background creamy. The mood is quiet and determined, with natural skin tones, earthy reds, and fresh greens. No blue cast, no text, no logos.
peptides

Athletes Have 59% More MOTS-c Before Anyone Injects a Thing

BY HELIX WARD ·

A small new study found that elite athletes carry about 59% more circulating MOTS-c than sedentary young men, with no injections involved. MOTS-c is a mitochondrial peptide often pitched online as an "exercise mimetic." Across 30 young males in three fitness tiers, higher levels tracked with VO2max and with lower post-exercise oxidative damage. But the design is cross-sectional with just 10 people per group, so it cannot show cause and effect, and it contains no data on injected MOTS-c. Here is what the numbers show, what they don't, and what it means if you're tempted by the vial.

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Didn't Shrink Human Muscle Cells. So Why the Muscle Loss?

BY DR. SYNAPSE ·

Does semaglutide really eat your muscle? A new GeroScience study put the drug straight onto primary human muscle cells from older adults with obesity, and the cells didn't waste. No atrophy genes switched on, no secretome alarms, and GIP even thickened myotubes after eight days. Semaglutide did modestly dial down glycolytic ATP production, and GLP-1 receptors were barely detectable. The findings point toward indirect causes of lean mass loss, like calorie deficit and reduced loading, though a dish is not a body.

Approach: conceptual metaphor. Palette: D, bold color field.

A single steel dumbbell sits in the center of a saturated tomato-red seamless backdrop. A thick, taut rope of frayed tan fibers wraps around its handle, and a few strands are visibly thinning and unraveling at one end while the rest stay dense and intact, standing for muscle being preserved while weight drops. Shot at a low three-quarter angle with a shallow depth of field, so the knurled grip texture is crisp and the background melts into smooth red. Hard, directional studio light from the upper left casts a sharp, short shadow on the glossy red surface. One thin electric green cable tie is cinched around the rope. The mood is punchy, tense and editorial, with no people and no text.
peptides

What to Pair With Tirzepatide to Keep Muscle? Mice Have a Clue

BY NOVA CHEN ·

Tirzepatide can strip off weight fast, but what happens to your muscle? A new mouse study tested the drug alone and stacked with time-restricted feeding and resistance training. The full stack accelerated weight and fat loss, resistance training preserved muscle and strength, and TRF plus tirzepatide improved glucose tolerance. The liver benefits, however, were the same across all treatments. This is animal-only research in obese female mice, so treat it as a promising signal, not a human protocol.

This page is available in